Can Adults in Their 40s Get the Arexvy RSV Vaccine? Eligibility Explained
REGOLITH English ·
Video description
South Korea expanded the approved indications for the RSV vaccine Arexvy in July 2026. Learn which high-risk adults aged 18–49 may qualify, how eligibility differs for adults in their 50s and those aged 60 and older, which RSV vaccines are available in South Korea, out-of-pocket costs, and precautions before vaccination.
00:00 Adults Under 50 May Qualify
00:41 Why RSV Risk Matters
01:32 Which Conditions May Qualify?
02:29 A Diagnosis Does Not Guarantee Eligibility
03:22 How Eligibility Changes With Age
04:12 Which RSV Vaccines Are Available in South Korea?
05:07 Medical Checks Before Vaccination
06:00 Evidence, Costs, and Questions for Your Clinic
This video includes AI-generated explanatory images and synthetic narration.
More videos
- Arexvy for Adults Under 50: Who Qualifies?
- 2027 Long-Term Care Insurance: How Much More Will Your Paycheck Lose?
- South Korea's 2027 Long-Term Care Insurance Increase: Your Actual Monthly Cost
- Can 40-Somethings with Diabetes Get the RSV Vaccine Arexvy?
- 2027 Long-Term Care Insurance Premiums: How Much More Will You Pay Based on Your Salary?
- Can People in Their 40s Get the Arexvy RSV Vaccine? High-Risk Criteria and Vaccination Guidelines...